450 related articles for article (PubMed ID: 10473112)
21. Analysis of downstream effectors of p53 on cell growth arrest and apoptosis induced by a temperature-sensitive Val138 mutant.
Wang FJ
J Med Dent Sci; 1998 Jun; 45(2):141-9. PubMed ID: 11186200
[TBL] [Abstract][Full Text] [Related]
22. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells.
Mitlianga PG; Gomez-Manzano C; Kyritsis AP; Fueyo J
Int J Oncol; 2002 Nov; 21(5):1015-20. PubMed ID: 12370749
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.
Blattner C; Sparks A; Lane D
Mol Cell Biol; 1999 May; 19(5):3704-13. PubMed ID: 10207094
[TBL] [Abstract][Full Text] [Related]
25. Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1.
Shelat HS; Liu TJ; Hickman-Bick DL; Barnhart MK; Vida T; Dillard PM; Willerson JT; Zoldhelyi P
Circulation; 2001 Jan; 103(3):407-14. PubMed ID: 11157693
[TBL] [Abstract][Full Text] [Related]
26. Human ARF binds E2F1 and inhibits its transcriptional activity.
Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
[TBL] [Abstract][Full Text] [Related]
27. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
28. Apoptotic and growth-promoting activity of E2F modulated by MDM2.
Loughran O; La Thangue NB
Mol Cell Biol; 2000 Mar; 20(6):2186-97. PubMed ID: 10688665
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
30. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
[TBL] [Abstract][Full Text] [Related]
31. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
32. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
33. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
Agah R; Kirshenbaum LA; Abdellatif M; Truong LD; Chakraborty S; Michael LH; Schneider MD
J Clin Invest; 1997 Dec; 100(11):2722-8. PubMed ID: 9389735
[TBL] [Abstract][Full Text] [Related]
34. Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.
Reinke V; Bortner DM; Amelse LL; Lundgren K; Rosenberg MP; Finlay CA; Lozano G
Cell Growth Differ; 1999 Mar; 10(3):147-54. PubMed ID: 10099828
[TBL] [Abstract][Full Text] [Related]
35. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
36. Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models.
Zhang Z; Wang H; Prasad G; Li M; Yu D; Bonner JA; Agrawal S; Zhang R
Clin Cancer Res; 2004 Feb; 10(4):1263-73. PubMed ID: 14977824
[TBL] [Abstract][Full Text] [Related]
37. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.
Nip J; Strom DK; Fee BE; Zambetti G; Cleveland JL; Hiebert SW
Mol Cell Biol; 1997 Mar; 17(3):1049-56. PubMed ID: 9032231
[TBL] [Abstract][Full Text] [Related]
38. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3.
Giovanni A; Keramaris E; Morris EJ; Hou ST; O'Hare M; Dyson N; Robertson GS; Slack RS; Park DS
J Biol Chem; 2000 Apr; 275(16):11553-60. PubMed ID: 10766769
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo.
Fueyo J; Gomez-Manzano C; Yung WK; Liu TJ; Alemany R; McDonnell TJ; Shi X; Rao JS; Levin VA; Kyritsis AP
Nat Med; 1998 Jun; 4(6):685-90. PubMed ID: 9623977
[TBL] [Abstract][Full Text] [Related]
40. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]